Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase NA 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphomatoid Papulosis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Disease 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Radiosurgery 27Blood Specimen Collection 20Drug Therapy 18Radiotherapy 14Early Intervention, Educational 14Magnetic Resonance Spectroscopy 13Standard of Care 12Pemetrexed 12Carboplatin 12Exercise 11Practice Guidelines as Topic 9X-Rays 8Psychiatric Rehabilitation 8Methods 8Immunotherapy 8Therapeutics 7Surgical Procedures, Operative 7Paclitaxel 7Fluorodeoxyglucose F18 7Surveys and Questionnaires 6Counseling 6Cisplatin 6Biopsy 6Anterior Temporal Lobectomy 6Thoracic Surgery, Video-Assisted 5Liquid Biopsy 5Gemcitabine 5Erlotinib Hydrochloride 5Docetaxel 5Bevacizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Non-Small-Cell Lung × Bexarotene × Clear all
NCT00125372 2019-01-08

Study of Tarceva and Targretin in Stage I-II Lung Cancer

Dartmouth-Hitchcock Medical Center

Phase NA Completed
12 enrolled 10 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡